Rajesh Kumar
Stock Analyst at HSBC
(2.53)
# 2,260
Out of 5,147 analysts
29
Total ratings
47.37%
Success rate
4.93%
Average return
Main Sectors:
Stocks Rated by Rajesh Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Downgrades: Reduce | $144 → $143 | $191.82 | -25.45% | 1 | Dec 10, 2025 | |
| ABBV AbbVie | Upgrades: Buy | $225 → $265 | $232.08 | +14.18% | 5 | Dec 10, 2025 | |
| NVO Novo Nordisk | Downgrades: Hold | n/a | $37.45 | - | 3 | Nov 24, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $235 | $178.81 | +31.42% | 2 | Oct 9, 2025 | |
| LLY Eli Lilly and Company | Upgrades: Hold | $675 → $700 | $1,051.99 | -33.46% | 3 | Aug 27, 2025 | |
| KDP Keurig Dr Pepper | Upgrades: Buy | $36 → $42 | $30.28 | +38.71% | 1 | Apr 25, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $660 → $670 | $521.11 | +28.57% | 3 | Apr 30, 2024 | |
| DHR Danaher | Upgrades: Buy | $250 → $280 | $210.64 | +32.93% | 2 | Apr 17, 2024 | |
| UNH UnitedHealth Group | Upgrades: Hold | $460 | $293.27 | +56.85% | 2 | Apr 4, 2024 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $13 | $33.86 | -61.61% | 1 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $55 → $53 | $62.37 | -15.02% | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Reduce | $97 | $53.57 | +81.07% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $110.23 | +12.49% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $27.65 | +80.83% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $123 | $123.82 | -0.66% | 1 | Jul 14, 2023 |
Biogen
Dec 10, 2025
Downgrades: Reduce
Price Target: $144 → $143
Current: $191.82
Upside: -25.45%
AbbVie
Dec 10, 2025
Upgrades: Buy
Price Target: $225 → $265
Current: $232.08
Upside: +14.18%
Novo Nordisk
Nov 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $37.45
Upside: -
IQVIA Holdings
Oct 9, 2025
Upgrades: Buy
Price Target: $195 → $235
Current: $178.81
Upside: +31.42%
Eli Lilly and Company
Aug 27, 2025
Upgrades: Hold
Price Target: $675 → $700
Current: $1,051.99
Upside: -33.46%
Keurig Dr Pepper
Apr 25, 2025
Upgrades: Buy
Price Target: $36 → $42
Current: $30.28
Upside: +38.71%
Thermo Fisher Scientific
Apr 30, 2024
Maintains: Buy
Price Target: $660 → $670
Current: $521.11
Upside: +28.57%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250 → $280
Current: $210.64
Upside: +32.93%
UnitedHealth Group
Apr 4, 2024
Upgrades: Hold
Price Target: $460
Current: $293.27
Upside: +56.85%
Teva Pharmaceutical Industries
Dec 18, 2023
Initiates: Buy
Price Target: $13
Current: $33.86
Upside: -61.61%
Oct 27, 2023
Upgrades: Hold
Price Target: $55 → $53
Current: $62.37
Upside: -15.02%
Jul 14, 2023
Initiates: Reduce
Price Target: $97
Current: $53.57
Upside: +81.07%
Jul 14, 2023
Initiates: Buy
Price Target: $124
Current: $110.23
Upside: +12.49%
Jul 14, 2023
Initiates: Buy
Price Target: $50
Current: $27.65
Upside: +80.83%
Jul 14, 2023
Initiates: Hold
Price Target: $123
Current: $123.82
Upside: -0.66%